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ABSTRACT 
 
 
Melody Bauer: Transatlantic Differences in GMO Preferences 
(Under the direction of Gary Marks) 
 
 
The transatlantic divide between the United States and the European Union on genetically 
modified organisms is reflected in the distinct regulatory approaches, levels in crop cultivation, 
and consumer acceptance. The purpose of this paper is to outline the key characteristics of the 
different attitudes and regulatory approaches on genetically engineered crops and food as well as 
connect the dots of the preferences of the actors involved and how they have influenced 
consumers’ preferences, the policymaking process, and regulatory outcomes. Public opinion, 
institutional structures, and cultural approaches to agriculture, and land usage are among the key 
features that help to explain the contrasting approaches and regulations seen in the United States 
and the European Union.  
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SETTING THE STAGE 
Introduction   
There is a transatlantic divide between the United States (US) and the European Union 
(EU) when it comes to genetically modified organisms (GMOs), which is reflected in distinct 
regulatory approaches, levels in crop cultivation, and consumer acceptance. To varying degrees 
in the US and the EU, the preferences of various actors, such as government regulators, 
biotechnology companies, civil society, and consumers, have played a role in shaping the 
perceived benefit-risk narrative on genetic technology and the subsequent regulations. The 
relatively relaxed policies in the US, based on the substantial equivalence principle, stand in 
contrast to the EU’s complex regulations, which contain precautionary clauses on traceability, 
mandatory labeling and thresholds for tolerable “contamination” of non-genetically modified 
products (Lau, 2015; Stephan, 2015).  
 The process of creating government regulation is not always straightforward, with 
various stakeholders vying to influence the policy process. Citizens and advocacy groups can 
participate through direct actions, demonstrations, media campaigns, or direct lobbying of 
industry or government, while mass media and the Internet provide fora for networking, 
collaboration, information dissemination, and public education by all actors involved. In 
addition, government institutional structures contribute to the decision-making process by 
predicting the level of participation of the stakeholders involved in the policy process (Einsiedel 
& Kamara, 2006). This is evident in the developments in the two regions: the process in the US 
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has been remarkably stable and permissive since the 1980s, whereas public unease in Europe led 
to an increasingly negative environment toward agricultural biotechnology.  
GMO acceptance can also be understood in the context of contrasting cultural identities, 
agricultural practices, and perceptions of land usage. American and European societies have 
historically moved along distinct cultural trajectories: American society, accelerated by 
industrialist and progressive forces, embraced a utilitarian approach to technology in agriculture, 
whereas many European societies continue to maintain traditional conceptions of cultural 
identity, “naturalness,” and moral worldviews (Stephan, 2012). While cultural identities and 
values may not cause specific outcomes, they create the essential, enabling conditions for 
political mobilization, and remain highly influential in shaping the public’s judgments on, and 
degree of support for, GMOs. Thus, understanding the regulatory divide between the two regions 
requires considering not only domestic politics but also the long-term historical evolution of 
these regions (Earle & Cvetkovich, 1995; Stephan, 2012, 2015).  
Table 1 provides an overview of the key characteristics of the transatlantic attitudes and 
regulatory approaches on GMOs discussed throughout this paper. Public opinion, institutional 
structures, cultural approaches to agriculture, and land usage are among the key features 
influencing the contrasting approaches and regulatory outcomes seen in the US and the EU.  
Ultimately, I will seek to understand the influence of some of the actors involved on the different 
regulatory approaches, and to what extent the differences (for example, cultural and/or 
institutional) between these two regions also act as intervening variables. 
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Table 1: Contrasting attitudes and regulations on GMOs 
Factors United States European Union 
Regulation Permissive environment; 
principle of substantial 
equivalence; GM foods and 
crops are prevalent in the 
marketplace 
Negative regulatory 
environment; precautionary 
principle; variations of 
acceptance in member states, 
with the majority being 
hesitant or hostile toward 
GMOs 
Public opinion Public is generally optimistic, 
with a minority opposed to 
GMOs; less favorable 
opportunity structures for anti-
GMO movement 
Initial lack of public trust; 
influence of anti-GMO 
movement; public is generally 
pessimistic toward 
agrobiotechnology 
Institutional structures Strong biotechnology sector 
and strong pro-
agrobiotechnology coalition in 
government and industry 
Complexities of multilevel 
governance 
Cultural approaches to 
agriculture and land usage 
Modern, bifurcated approach 
to agriculture; values of 
efficiency, productivity, and 
utilitarianism 
Interactive agricultural 
communities; traditional 
concepts of naturalness, 
cultural identities and 
livelihoods 
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Agricultural biotechnology 101 
 Biotechnology can be defined as “any technological application that uses biological 
systems, living organisms, or derivatives thereof to make or to modify products or processes for 
a specific use” (United Nations, 1992, p. 3). Biotechnology is in itself nothing new. Humans 
have bred crops selectively for environmental robustness or higher yields for several thousands 
of years, and the knowledge of crossbreeding can be traced back to the start of sedentary 
agriculture (Stephan, 2012). However, the advances of molecular genetics in the 1970s and 
1980s enabled the selection of a specific part of a gene, or genes, responsible for producing an 
attribute in a plant or animal, such as the production of an enzyme or resistance to a particular 
disease. These genes could then be multiplied to increase a specific effect or added to an entirely 
different microorganism, animal, or plant. These technological developments in genetic 
engineering facilitated the targeted modification of an organism beyond traditional breeding 
methods (TNS Opinion & Social, 2010). 
Since the 1980s, biologists have used genetic engineering to alter a plant’s characteristics, 
such as to increase resistance to diseases or longer shelf life for fruit. In 1994, Calgene’s FLAVR 
SAVR tomato was the first genetically engineered food product to be commercialized in the US 
market. Only some 1.7 million hectares of insect resistant Bacillus thuringiensis (Bt) corn and 
cotton as well as transgenic herbicide-tolerant oilseed rape and soybeans were cultivated globally 
in 1996, the year GM crops were commercialized (Lucht, 2015). By 2016, 185.1 million hectares 
of genetically modified crops were planted by some 18 million farmers in 26 countries—an 
increase of 110%1 (National Academy of Sciences [NAS], 2016). GM crops are cultivated 
predominately in the Americas, with the US (72.9 million hectares in 2016), Brazil (49.1) and 
Argentina (23.8) being the top producers; whereas only 136 hectares were cultivated in five EU 
                                                 
1 Or about 12% of the world’s cropland in 2016 (NAS, 2016). 
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member states (mostly in Spain) for 0.07% of the global total (International Service for the 
Acquisition of Agri-biotech Applications [ISAAA], 2016). Genetically modified crops continue 
to spread globally and are considered the fastest adopted crop technology in the history of 
modern agriculture (NAS, 2016).  
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OVERVIEW OF GMO REGULATORY DEVELOPMENTS IN THE US AND THE EU 
US regulatory system for GMOs 
From the onset, genetic technologies have been the subject of regulatory controversy. The 
development of recombinant deoxyribonucleic acid (rDNA) techniques in the US during the 
1970s sparked intense debate within the wider scientific community as well as public concern 
that mutant organisms might be released into the environment (Marden, 2003). The 1974 Berg 
letter to Science and Nature, signed by a number of prominent researchers, invited scientists 
from around the world to defer voluntarily from conducting rDNA experiments until the 
potential risks of such molecules had been better evaluated or adequate methods had been 
developed for preventing their spread (Gaskell & Bauer, 2006). In February 1975, 140 scientists 
and lawyers convened at the Asilomar conference to discuss the ramifications of the scientific 
breakthrough. They decided to introduce responsible self-regulation in order to mitigate future 
state and federal government regulation of genetic engineering and adopted interim guidelines, 
which were then endorsed by the National Institutes of Health, a US federal medical research 
agency.  These guidelines and their apparent effectiveness at biological containment were a 
soothing gesture to American lawmakers and the US public at large and set the stage for 
declining public interest in novel genetic techniques. Additionally, the lack of safety crises in the 
US in the ensuing years allowed rDNA research to gain respectability (Marden, 2003; Stephan, 
2015). 
By the 1980s, the introduction of GM crops and foods to commercial markets was 
imminent, raising environmental and safety concerns. There were congressional hearings on GM 
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technology and a movement to draft new legislation specific to its application. As a result of 
American scientists being the first movers in both the scientific and regulatory aspects of 
biotechnology, the US had developed its position as a global leader in the field, and scientists 
and governments supporters were reluctant to cede this (Marden, 2003; Stephan, 2015).  
In 1986, the finalized Coordinated Framework for the Regulation of Biotechnology2 
outlined the coordinated, risk-based system of the federal agencies involved with the review of 
biotechnology research and products. The US policy was built on three tenets: (1) the substantial 
equivalence principle: a focus on the substantial equivalence of a GM crop or food product to a 
traditional counterpart in terms of composition, nutrition, and safety, rather than on the fact that 
genetic engineering was used in the process; (2) only regulation grounded in verifiable scientific 
risk would be tolerated; and (3) as the technology used in GM products is on a continuum with 
other agricultural innovations, any risks are seen as similar to those of traditionally produced 
foods (Marden, 2003; Lau, 2015; USDA-APHIS, 2017). Ultimately, the approach was that 
effective scientific and industry self-regulation could preclude inhibitory legislation, ensuring the 
development of the GMO industry (Marden, 2003).  
In the US, three federal agencies are responsible for regulating GM products under the 
same laws governing the health, safety, efficacy, and environmental impacts of conventional 
products. The Department of Agriculture Animal and Health Plant Inspection Service (USDA-
APHIS) controls the importation, handling, interstate movement, and environmental release of 
transgenic plants, with the aim of protecting existing crops from risk. The Department of Health 
and Human Services Food and Drug Administration (FDA) regulates GMOs in food, drugs, and 
biological products, while GMO microorganisms and pesticides are managed by the 
                                                 
2 This was proposed by the Reagan administration and further developed by both the George H. W. Bush 
and Clinton administrations (Marden, 2003). 
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Environmental Protection Agency (EPA). Officials of the three regulatory agencies collaborate 
to ensure that any arising safety or regulatory issues are appropriately resolved (USDA-APHIS, 
2017; the Library of Congress, 2015).  
Depending on the characteristics of a given GM product, it may be subject to the 
jurisdiction of one or more of these agencies. The USDA requires businesses to submit a wide 
range of information before GM plants can be introduced in the US under regulated or 
nonregulated status. New GM foods require premarket approval if they contain high levels of 
allergens or toxic substances or reduced levels of essential nutrients3; the FDA recommends a 
voluntary consultation process to determine whether new products would require this approval. 
However, as GM foods fall under the FDA classification of “generally recognized as safe,” they 
typically do not require special labeling or premarket approval (Lau, 2015; FDA, 2018). The 
more lenient approach seen in the US is complemented by the threat of litigation against both 
individual companies and federal regulators (Stephan, 2015). 
Some argue that, “The core scientific principles of US regulations, such as ‘substantial 
equivalence,’ cannot be understood outside their political, legal, and cultural context” (Stephan, 
2015, p. 17) and that regulatory outcomes are partial to what benefits food producers and 
retailers. In addition, the revolving door migration among agrobiotechnology industry lobbyists 
and regulators is seen not only as a political foible but also as an expression of a wider belief 
system that produces a far-reaching consensus between the two groups: to lobbyists and 
regulators, GM products are generally progressive and benign and offer impressive economic 
opportunities. The data on American public opinion4 indicate that the general population holds a 
                                                 
3 Insecticides are a special subclass under the jurisdiction of the EPA (Lau, 2015). 
 
4 More on this in the following section.  
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largely positive reading of technological progress, albeit with weaker confidence in its safety and 
latent concerns about physical and moral ramifications (Stephan, 2015).  
GMO regulations in Europe 
The American approach to regulation stands in contrast to developments in Europe. In the 
early 1990s, the topic of GM foods in the EU remained limited to parliamentary debates about 
the transposition of European directives concerning the dissemination of GMOs and to various 
media articles on biotechnology. The use and commercialization of GMOs started to gain 
traction with the public at the end of 1996 when animated debate surrounded the authorization of 
Bt corn and the very first imports of transgenic seeds arrived in Europe from the US. Public 
opinion was marked strongly at this stage by various completely legitimate scares, such as 
bovine spongiform encephalopathy (BSE), HIV-contaminated blood, asbestos, and other 
perceived regulatory failures. While these issues had nothing to do with GM foods, they led to 
strong public distrust toward the food and agricultural industry and government regulatory 
agencies, which were perceived as potentially disregarding health risks in order to protect certain 
political or economic interests (Bonny, 2003; Paarlberg, 2014). 
Trust is an important factor for the perception of many types of risk, including those 
related to GM foods (Land & Hallman, 2005). As Dan Glickman, former US Secretary of 
Agriculture, observes: 
With all that biotechnology has to offer, it is nothing if it’s not accepted. This boils down 
to a matter of trust. Trust in the science behind the process, but particularly trust in the 
regulatory process that ensures thorough review—including complete and open public 
involvement. (Glickman, 1999) 
 
Thus, because confidence in European government institutions, industry, and certain 
technological advances had decreased at the time when genetic engineering issues were being 
widely publicized, coordinated anti-GMO campaigns were successful in influencing the national 
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debates on GM crops and foods in many European countries. European NGOs, such as Friends 
of the Earth, Greenpeace, and the European Consumer Organisation (BEUC), saw no consumer 
benefit from GM foods that might justify even a hypothetical risk and began warning consumers 
against such products, simply on precautionary grounds (Paarlberg, 2014).  
As a wave of public opposition to GMOs swept through Europe, the EU’s initial Novel 
Foods Regulation in 1997, which included relatively moderate provisions on GMOs, became 
meaningless (Stephan, 2015). The anxieties of European consumers led several EU member 
states to resort to national bans on GM crops and the European Commission to establish its 
general policy for GM food regulation in 2002. The Commission also founded the European 
Food Safety Authority (EFSA), a scientific committee and the legislative body responsible for 
conducting environmental and health risk assessments of any GMO to be cultivated or marketed 
within the EU (Regulation (EC) 178/2002).  
In addition to the public outrage caused by various food-industry related crises in the 
1990s, the EU’s tradition of risk-averse regulation in other areas meant that the precautionary 
principle became the central tenet for GMO regulation. Detailed in Article 191 of the Treaty of 
the Functioning of the European Union, the precautionary principle is a risk management 
strategy whereby if a given policy or action may cause harm to the public or environment, and if 
there is no scientific consensus on the issue, the policy or action in question should not be 
pursued (EUR-Lex, 2016; European Commission, 2015). 5 The European legislation on GMOs 
(for example, Regulation (EC) 1829/2003 on GM food and feed, Regulation (EC) 1830/2003 
concerning the labeling and traceability of GMOs and GM products, and Directive 2009/41/EC 
                                                 
5 The situation should be reviewed, however, once more scientific information is available. The 
precautionary principle should also “only be invoked in the event of a potential risk and can never justify 
arbitrary decisions” (EUR-Lex, 2016). 
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on the contained use of GM microorganisms) seeks to protect the environment and human and 
animal health, defend consumer interests, and ensure that the EU’s single market works 
effectively (Regulation (EC) 178/2002). 
The EU’s GMO authorization process includes extensive and case-by-case assessment by 
the EFSA. The labeling and traceability regulations of GM foods are both process- and product-
oriented and aim to label goods that involve genetic engineering at any stage of production. 
Labeling is required for food products that contain over 0.9% of biotechnological events 
(Regulation (EC) 1829/2003) and for GMOs for food use, food items containing or consisting of 
GMOs, and GMO derivatives, regardless of whether or not the GMOs are detectable in the end 
product (for example, sugar from GM sugar beets) (Regulation (EC) 1830/2003; Henard et al., 
2012; European Commission, 2015).6 
Approval of GM crops at the EU level can conflict with the regulatory policies of 
individual member states, and the ultimate deciding power rests with member states. The de 
facto moratorium initially set by various EU countries on the cultivation and importation of GM 
seeds and foods continues today, with Directive (EU) 2015/412 allowing EU member states to 
challenge EFSA risk assessments and to restrict or prohibit the cultivation and use of a particular 
EU-approved GMO within their borders, if the member state provides additional data 
demonstrating that the GMO poses a risk to environmental or human health (EC 
MEMO/15/4779). However, such challenges are brought primarily for political or economic 
                                                 
6 In the context of the EU’s strict regulations, it is interesting to note that numerous products are exempt 
from GMO labeling obligations. Enzymes produced by GM microorganisms used as processing aids 
(Twardowski & Malyska, 2015) as well as animal products, such as dairy, meat, and egg products, 
derived from animals fed GM ingredients also do not require GM labels, despite the fact that imported 
GM soybean meal is a major feed ingredient for most poultry and livestock in Europe. The EU imports 
annually some 32 million metric tons of soybeans and soybean meal to be used in feed protein; nearly all 
of it is from genetically engineered varieties. Non-GM feeds account for less than 15% of total compound 
feed production in the EU (Henard et al., 2012). 
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reasons. An example of this is France’s ban in 2008 of EU-approved MON810 corn, which 
contains an engineered insecticidal protein. France alleged that MON810 was an environmental 
risk because of the potential for insects to develop resistance to insecticide (the hypothetical 
impacts had been rejected by the EFSA). Because the scientific basis of the ban was unclear, the 
French government’s position was seen as being largely (bio)political, with ministers deciding 
against scientific opinion to give the appearance of being “green” for the sake of political 
expediency. The French ban of MON810 was declared unlawful by the European Court of 
Justice in 2011, yet the French government continues to ban MON810. France’s moratorium on 
MON810 and other similar restrictions by individual EU member states indicate “government 
interference with science to justify political handling of risk management and bypass European 
and national agencies in charge of biotech risk assessment under European directives” (Kuntz et 
al., 2013, p. 499). 
The variations in acceptance of agricultural biotechnology and GM foods between EU 
member states are greater than the variances in socio-demographic characteristics typically 
observed in surveys (for example, age, gender, profession, level of education, etc.) (Gaskell et 
al., 2010). These differences are reflected in the diverging policies, private attitudes, and 
agricultural and industrial approaches, with some European countries being more favorable or 
less hostile to genetic technology, and others being more hostile. The member states that are 
open to genetic engineering include GM crop producers: Spain, Portugal, the Czech Republic, 
Slovakia, and Romania. States ready to adopt locally cultivated crops, if EU approval is granted 
include: the United Kingdom (UK), Ireland, Denmark, Estonia, Finland, Lithuania, and Sweden. 
Then there are those countries that are hesitant to adopt biotechnology and where there are 
contradictory forces: the Netherlands, the Flanders region of Belgium, Bulgaria, France, and 
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Germany. Finally, there are several member states that are opposed to biotechnology: Austria, 
Hungary, Slovenia, the Wallonia region of Belgium, Luxembourg, Greece, Italy, and Latvia 
(Henard et al., 2012). 
Despite the Commission’s stated priority for a science-based policy geared toward a 
knowledge-based bio-economy, country-specific pressures have influenced the legal framework. 
John Dalli, a former EU Health and Consumer Policy Commissioner, maintains that, “The 
problems of implementation of the GMO legislation [at the EU level] do not stem from its design 
or its objectives, which remain relevant, but rather from the way these sensitive issues are 
handled at a political level” (European Commission, 2011). The multilevel governance of the EU 
grants member states the role of principal agents of enforcement (with many veto points), 
assuming formal political roles in European regulatory committees, the Council of Ministers and 
the European Parliament, while US states have little say in the decision-making processes of 
federal regulatory authorities (Toke, 2004; Stephan, 2015).  
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PUBLIC ATTITUDES AND CULTURAL CONTEXT 
Public attitudes toward GM crops and foods 
In addition to regulation, public perception may be a significant hurdle to the acceptance 
of new technology. Consumers are generally keen to know about the foods they eat, sources of 
food, and, if the food is processed, what ingredients may have been added (Wunderlich & Gatto, 
2015). Because the average consumer does not have the scientific knowledge or resources to 
decide for her/himself whether GM foods constitute a risk, they have to rely on the competence, 
transparency, and honesty of the various actors participating in the food supply chain to assess 
the risk of eating GM foods. Thus, trust is an essential component of public perception and 
acceptance of genetic technology, with a broad range of actors—from civil society, scientists, 
regulatory agencies, industry, and the media—contributing to the formation of this trust (Lang & 
Hallman, 2004). The degree of trust that the public places in actors and institutions is influenced 
by the wider cultural context (Stephan, 2012).  
Consumer concerns about the safety of GMOs can have a direct impact on GMO 
management, and various forums of public involvement provide opportunities for the public to 
affect the policies, and therefore trajectories, of technology. Whether the public displays trust 
toward the institutions that appear to control GMOs is a crucial issue for academics and 
policymakers interested in understanding consumers’ reactions to GM foods (Lang & Hallman, 
2005; Gaskell & Bauer, 2006). Surveys provide quantitative data that offer a glimpse of public 
opinion and have been used widely in both the US and the EU. However, it is worth noting that 
different surveys often come to contradictory conclusions despite questioning the same public; as 
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Stephan notes, “Too much evidently depends on how questions are framed, on what terminology 
is used or on what information is supplied” (2015, p. 17). 
Well before the safety crises that triggered the anti-GMO events in Europe, a groundswell 
of opposition was detected, with a sizeable majority of Europeans considering agrobiotechnology 
applications as harmful to health and the environment and 85% of respondents calling for stricter 
regulations (Zechendorf, 1994). Surveys since the early 1990s showed that members of the 
European public had generally not yet made up their minds about biotechnology, but that if they 
did want more information, they were more likely to trust anti-GMO groups espousing negative, 
value-based attitudes toward the technology than to trust industry and government sources (Tait, 
2001).  Anti-GMO groups made a strong impact on public perception, and they received 
extensive publicity due to the dynamism of their actions: countless mass dissemination of 
warnings, petitions, alerts, and leaflets; standard letters to elected officials and agricultural firms; 
lawsuits; demonstrations; and sabotaging GM crop trials and imports. The endless circulation 
and use of anti-GMO information on the Internet gave it credibility; compound repetitions made 
it seem more reliable (Bonny, 2003). However, much of the anti-GMO information in circulation 
at the time was partial and biased; examples of comments from anti-GMO activists include the 
following: “GMOs are unsafe and must never be released into the environment.” “We don’t 
know enough about GMOs to risk releasing them—what is being done about this?” “Why 
doesn’t someone do something to understand the risks of what GMOs are?” (EUR 24473, 2010, 
p. 209). The 1999 Eurobarometer showed that, in regards to GMOs, actors judged by 
respondents to be “doing a good job for society” were primarily consumers’ unions, doctors, the 
media, and environmentalist groups, while industry was judged as the only actor most often “not 
doing a good job” for society regarding GMOs (Eurobarometer 52.1., 2000).  
 16 
There is a greater focus nowadays on new technologies as a result of increased concern 
about sustainability, with Europeans favoring the impetus toward innovation so long as the 
public is involved in decisions about new technologies when social values are at stake and there 
are appropriate regulations to balance the market. The latest Eurobarometer in 2010 indicates 
that while the crisis of confidence in regulation and technology that characterized the 1990s is no 
longer the dominant perspective in Europe, GM foods remain the Achilles’ heel of 
biotechnology. Although attitudes toward genetic engineering improved slightly after the peak of 
public opposition from 1996 to 2000, the overall picture throughout 1996 to 2010 as presented in 
Figure 1 and Table 2 is one of declining support across many European countries; opponents 
outnumber supporters three to one, and in no country is there a majority of supporters7 (Gaskell 
et al., 2006, 2010).  
 
 
 
                                                 
7 In the 2005 Eurobarometer, only 27% of respondents regarded GM food positively; this number dropped 
to 23% by 2010 (Gaskell et al., 2010). 
 
Source: Gaskell et al., 2010, p. 37 
 
Figure 1: Support for GM foods in the (then) 27 EU member states 
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In general, respondents believe that the governance of science should be based on moral 
and ethical considerations rather than scientific evidence (Gaskell et al., 2010).  Member states 
with a ban on GM crop plantings generally show low values of public support and vice versa. 
For example, amongst European countries, Spain has registered the highest index level of public 
optimism for biotechnology/genetic engineering concurrently between 1991 to 2010. Spain is 
also the EU’s leading producer of Bt corn with over 90% of total acreage in the EU (or 30% of 
the annual Spanish corn crop) (Gaskell et al., 2010). Since Bt corn was first planted in Spain in 
1998, farmers have had good experiences with the crop’s efficacy against the corn border 
infestation, which, together with reduced pesticides costs and yield gains, translates directly into 
increased revenues (Gómez-Barbero et al., 2008). 
 
Source: Gaskell et al., 2010, p. 40 
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Table 2: Trends in support for GM foods in Europe 
 
% of respondents who agree or totally agree that GM food should be encouraged 
 1996 1999 2002 2005 2010 
United Kingdom 52 37 46 35 44 
Ireland 57 45 57 43 37 
Portugal 63 47 56 56 37 
Spain 66 58 61 53 35 
Denmark 33 33 35 31 32 
Netherlands 59 53 52 27 30 
Norway 37 30   30 
Finland 65 57 56 38 30 
Belgium 57 40 39 28 28 
Sweden 35 33 41 24 28 
Italy 51 42 35 42 24 
Austria 22 26 33 24 23 
Germany 47 42 40 22 22 
Switzerland 34    20 
Luxembourg 44 29 26 16 19 
France 43 28 28 23 16 
Greece 49 21 26 14 10 
Czech Republic    57 41 
Slovakia    38 38 
Malta    51 32 
Hungary    29 32 
Poland    28 30 
Estonia    25 28 
Slovenia    23 21 
Latvia    19 14 
Lithuania    42 11 
Cyprus    19 10 
Iceland     39 
Romania     16 
Bulgaria     13 
Croatia     13 
Turkey     7 
Source: Gaskell et al., 2010, p. 40 
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The issues associated with food safety that Europeans are most concerned about include 
GMOs, pesticide residue, pollutants in food products, and the presence of antibiotics or 
hormones in meat (TNS Opinion & Social, 2010). Public concerns about risks and safety 
together with the perceived absence of benefits remain paramount issues; GM foods are seen as 
“unnatural,” and many Europeans report feeling uneasy about the notion of GM foods. However, 
while only a small number of GM-labeled products are on sale in various European countries, 
and a majority of the European public is somewhat averse to GMOs, studies have also found that 
most people are actually neither really interested in nor very alert to the presence of GM 
ingredients in products, even when present in the foods purchased. The quality in proportion to 
the price turned out to be a paramount concern, regardless of whether a food item was labelled 
GM. A 2010 study concluded: 
The observations underline the fact that what people say differs from what they do.  
Though the data obtained are not sufficiently extensive, it may reasonably conclude that 
(i) most people do not actively avoid GM foods while shopping, suggesting a divergence 
between their opinions and actual shopping patterns; (ii) linking purchasing data with 
answers to questionnaires is a more reliable way to establish attitudes than relying on 
opinion polls only. (EUR 24473, 2010, p. 209) 
 
The US was the initial driver and promoter of agricultural biotechnology, and legal 
actions rather than wide popular pressure gave rise to the country’s current regulatory framework 
(Stephan, 2015). The American government’s approach to GM products has helped the industry 
to grow: the country leads in biogenetic agricultural productions, contributing 72.9 million 
hectares of land and accounting for 40% of global GM crops (ISAAA, 2016). Over 100 GM 
crops with a single engineered trait have been introduced in the US market to date; by contrast, 
fewer than 40 have been introduced in the EU (Lau, 2015). Corn, cotton and soybeans—the three 
most widely grown GM crops in the US—initially accounted for only small percentages of 
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farmland in 1996 but now supersede conventional crop varieties, and the adoption rate of 
genetically engineered crop varieties is over 90% (Wunderlich & Gatto, 2015; Lucht, 2015). The 
majority of processed foods in the US contain at least one GM ingredient, and American 
consumers have been ingesting GMOs for the last two decades without ill effects (Funk & 
Kennedy, 2016). 
Although the US is sometimes portrayed as a non-contentious market, the picture of GM 
foods there is not always clear. Between two-thirds and three-quarters of American consumers 
initially expressed little to no concern about genetic techniques in food production and were 
likely to buy GM products (O’Connor et al., 2004). Marked US public concern about the 
technology did not emerge until 1997, driven in part by the controversy in Europe. While there 
have been repeated complaints from consumer groups, NGOs, and trade partners that the safety, 
allergenicity, and environmental concerns of GMOs have not been adequately considered, the 
opposition has not had the same pivotal influence as in the EU (Marden, 2003). There appears to 
have been a peak in both awareness and concern around 2000 to 2001; general public awareness 
reached 53%, and only half the population still believed in the substantial benefits of 
agrobiotechnology over the next 20 years. Opposition had again declined somewhat by 2006 and 
was estimated at 34% (Stephan, 2015). In a 2016 Pew Research Center survey (see Table 3), 
48% of respondents said the health effects of GM foods are no different from other foods, 39% 
said GM foods are worse for one’s health, and 10% said such foods are better for one’s health. 
Most Americans surveyed say they know little about GM foods, and many people hold “soft” 
views about their health effects. Sixteen percent (16%) of respondents, however, care a great 
deal about GM foods and believe they pose health and environmental risks (Funk & Kennedy, 
2016). 
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Table 3: Public opinion in the US on GM foods 
% of US adults who say foods with genetically modified ingredients are generally ____ than 
foods with no genetically modified ingredients 
If given an option of saying “not sure” 
Worse for health 
Neither better nor worse 
Better for health 
Not sure 
No answer (vol.) 
 
33 
32 
7 
26 
1 
Among those saying “not sure” 
Worse for health 
Neither better nor worse for health 
Better for health 
No answer (vol.) 
 
22 
58 
11 
10 
Views about GM foods when both questions are combined 
Worse for health 
Neither better nor worse for health 
Better for health 
No answer or refused to lean (vol.) 
 
39 
48 
10 
3 
Note: Respondents were first given the option of answering “not sure” when asked about the 
health impacts of genetically modified foods. Those respondents (and any who gave no 
answer) were then asked which option they were “leaning” toward if they had to choose. 
Source: Survey conducted May10-June 6, 2016. 
“The New Food Fights: US Public Divides Over Food Science” 
Pew Research Center 
 
 
A recent report from the National Academies of Sciences, Engineering, and Medicine 
suggests that while there is scientific consensus that GM foods are safe, many Americans 
perceive disagreement in the scientific community over whether or not GM foods are indeed safe 
to eat. This skepticism perhaps arises from concerns regarding the motives of research scientists, 
with some 30% of Americans believing that research findings on GM foods are often influenced 
by the researchers’ desire to help their industries. The same number of Americans also say that 
research findings on GM foods are influenced by the best available evidence. Generally, 
Source: Funk & Kennedy, 2016 
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Americans with greater knowledge of science topics are more likely to trust information from 
scientists and to see scientific research findings about GM foods in a more favorable light (Funk 
& Kennedy, 2016). The Eurobarometer showed comparable results regarding individuals who 
are more science savvy (Gaskell et al., 2010). 
In addition to the concerns raised over health and environmental risks, anti-GMO 
activism in the US in the early 2000s highlighted socio-economic arguments about the corporate 
monopoly control of the food chain and damage posed to small and organic farmers (Reisner, 
2001). Demands were made for the mandatory labeling of GMOs and more stringent evaluations 
of their potential negative impacts on the environment and human health. While these campaigns 
ultimately failed to reform the US regulatory framework, they did achieve some limited 
victories: In 2002, organic food labels were established, and the FDA announced more rigorous 
guidelines on premarket food safety evaluations in 2004. Numerous state bills and court cases 
yielded a patchwork of rudimentary segregation and labeling laws (Stephan, 2012). Several New 
England states with strong positions on organic farming have led the resistance against genetic 
engineering, requiring GE seed labels and allowing the voluntary labeling of GM-free products 
(Tokar, 2009). In 2014, Vermont was the first state in the US to pass legislation requiring the 
labeling of GM foods, effective July 1, 2016, while Maine and Connecticut passed similar 
labeling laws, albeit with a trigger clause requiring other states to pass labeling requirements 
before their own legislation goes into effect (Chokshi, 2014). 
While anti-GMO activism in Europe has been integral in mobilizing public pressure for 
stringent regulations, the success of these campaigns has been related to both political 
opportunity structures and the ability of anti-GMO narratives to activate widespread and 
preexisting, culture-based anxieties. American NGOs have attempted to replicate European 
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success but have faced a powerful pro-agrobiotechnology coalition and less favorable political 
opportunity structures. The differences in NGO narratives and the broader cultural context is 
reflected in the strategies of biotechnology industry and responses of farmers’ organizations: 
cautious incrementalism or indifference in Europe compared to American optimism (with some 
exceptions) (Stephan, 2012).  
Overall, the data from direct consumer surveys show that consumer knowledge of GMOs 
in both the US and Europe is generally low and remains superficial (Lucht, 2015; Wunderlich & 
Gatto, 2015). Survey respondents showing low GM knowledge also reported a 
disproportionately strong reliance on popular media as a source of information. This can be 
problematic, however, as the media can propel incomplete and simplified knowledge en masse, 
leading to partial or inaccurate knowledge and information (Wunderlich & Gatto, 2015). For 
example, the fact that intense research work is being done on the biosafety of GMOs is often 
ignored in the public debate. J. E. Bering maintains that anti-GMO activists: 
Have encouraged the exploited public unease very effectively because most people are 
unaware that biosafety research is being done and, with the exception of GM vaccines 
and other medical uses, there has been very little direct public benefit to counteract 
perceived risks. (cited in EUR 24473, 2010, p. 209) 
 
Although GMO-related information in the popular public sphere may not always originate from 
scientific sources, consumers are apt to trust these sources over mainstream scientific sources 
(Wunderlich & Gatto, 2015).  
Cultural approaches to agriculture and land usage 
 Explaining the divergent approaches between the US and the EU, however, goes beyond 
the typical debate about whether the US takes excessive risks for the sake of efficiency, or 
whether European countries are irrational in their insistent precaution and concern over the 
safety of GMOs. In addition to scientific information, the public’s perception of genetic 
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technology is influenced by cultural resources from one’s symbolic past (Gaskell & Bauer, 
2006).  
Numerous accounts of GMO regulation implicitly acknowledge that culture plays some 
role in regulatory outcomes, politics, and public opinion. Stephan (2015) notes that, “When 
rendered more explicit, cultural factors manifest themselves in terms of social trust, regulatory 
styles or traditions and public ‘outrage’” (p. 7). Culture embodies the context of political agency 
and “is the basis for social and political identity that affects how people line up and how they act 
on a wide range of matters” (Ross, 1997, p. 39). Cultural factors should be included as an 
integral part of an analysis that also considers other elements derived from regulatory politics, 
public mobilization, and interest group behavior (Stephan, 2015). Consequently, one manner 
through which GMO acceptance can be understood is in the context of different historical 
perceptions of land usage and agricultural practices.  
While European relations to the natural environment were marked with spiritual precepts 
and material interdependence, American settlers swiftly shook off their hereditary attitudes and 
undertook the challenge of mastering a “wild” continent. These dynamics produced divergent 
civilizations dispositions, or the tendency to perceive relations between nature and humanity as 
either interactive or bifurcated. American bifurcated approaches shifted from the interactive 
European tradition of pastoral beauty toward the magnificence of wilderness, albeit alongside a 
continued exploitation of the same. Nature has taken a meaning of grandeur and truth in the US, 
while in Europe it remains mired in compromises (Stephan, 2012).  
Agriculture in Europe is typically regarded as an integral part of the environment—the 
“middle landscape” wherein natural processes and human activity coexist. Farming, with its 
associated landscapes, livelihoods, and practices of food production, is a principal illustration of 
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the variety and overlap in land usage patterns (Stephan, 2012) and the accompanying “strong 
ideological and physical linkages between rural and urban” (Herrick, 2005, p. 291).  Methods of 
heavy plowing are deeply rooted in the European farming tradition, and no-tillage8 farming is 
rarely practiced (Eurostat, 2018). The pioneer aspect of American history created the notion of 
the need to “conquer” and win a livelihood from the wilderness, while in Europe, Romanticism 
in the nineteenth century saw the beginning of a shift away from technological mastery over 
nature. Additionally, the destruction of Europe during the two world wars of the twentieth 
century made it necessary to rebuild and restore European agriculture, while the mainland US 
remained untouched and continued to develop its agricultural production without the interference 
of conflict (Ujj, 2016). 
In Europe, only a relatively small area is currently under no-tillage in contrast to the US, 
Australia, Canada, Argentina, and Brazil (Mäder & Berner, 2012). American farmers are more 
reliant on herbicides in order to preserve soil quality. While tillage is a useful weed management 
option and makes the use of herbicides less necessary, it also dries and compacts soil, leading to 
extensive erosion, an undesirable trait particularly in the drier central and southwest US states 
(Ujj, 2016). The no-tillage method was adopted in the US after the Dust Bowl in the 1930s 
(Mäder & Berner, 2012). Prior to the tragic dust storms, the plow dominated American 
agriculture and represented the larger efforts of European settlers to transform and cultivate their 
newly homesteaded land. Heavy steel plows were applauded for their efficiency in creating a 
finely titled, smooth surface without residue. Throughout World War I, the US government 
encouraged the use of the steel plow in order to maximize production as part of the home front 
war effort. The push for maximum production, in addition to the use of the moldboard plow 
                                                 
8 No-tillage is a minimum tillage farming practice in which the crop is sown directly into soil that has not 
been tilled since the harvest of the previous crop. Weeds are controlled through the use of herbicides 
and/or appropriate mulching (Eurostat, 2018). 
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during a devastating drought, led to the 1930s Dust Bowl, in which an estimated 282 million 
acres of land—including 50 million acres of cropland—were destroyed by erosion and another 
100 million acres were severely damaged (Strand et al., 2014).  
 In 1935, the Senate Public Land Committee created the USDA Soil Conservation and 
advocates for soil conservation vilified the moldboard plow, equating soil erosion with poison 
that endangered an important resource and farmers’ livelihoods. These events, along with 
research in conservation tillage9, inspired the federal government to pass a series of policies that 
supported conservation tillage and to provide financial support to those farmers willing to adopt 
innovative conservation methods such as stubble mulching, contour plowing, ridge planting and 
terracing. Technology also evolved, making conservation tillage more accessible and efficient 
through the use of new equipment and practices such as herbicides and the Allis-Chalmers no-till 
planter. Overall, such developments and policies encouraged American farmers to adopt new 
practices in their soil management and engagement with agricultural landscapes (Strand et al., 
2014).  
In contrast to many farms in the US, European farmers in large spaces are faced with cold 
and humid conditions during crop cultivation, limiting the suitability of no-tillage practices 
(Mäder & Berner, 2012). Uptake of no-tillage ranges from 4.5% to 10% of total arable land in 
Greece and Finland, and from 2.5% to 4.5 percent in the UK, Spain, Slovakia and the Czech 
Republic. Reduced tillage is practiced on 20% to 25% of arable land in Portugal, Germany, and 
                                                 
9 Conservation agriculture comprises a combination of practices that minimize alteration of the structure 
and composition of soil, safeguarding it from erosion and preserving soil biodiversity. No-tillage and 
reduced tillage, combined with permanent soil cover and crop rotation, are essential practices in 
conservation agriculture. Such practices mitigate the risk of soil degradation by increasing the organic 
carbon stock, thus improving biological activity, the water-retention capacity of soils, and soil fertility 
and structure, which in turn reduce soil erosion and nutrient run-off, and improve soil resistance to 
compaction (EUR 23767, 2009). 
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France, and on 40% to 50% in the UK and Finland (EUR 23767, 2009). Mixed farms with 
fodder, animals and cash crops are instead considered ideal in view of environmental protection, 
nutrient recycling and a farm’s impact on the soil and climate (Mäder & Berner, 2012). 
The European pastoral idea of nature and landscape, which includes aesthetic and socio-
economic elements, continues and has fueled important movements of resistance against modern 
industrial or technological change (Stephan, 2015). Cultural identities have frequently drawn on 
images of agricultural and artisanal livelihoods and their associated humanized environments. 
While the arrival of technological changes are not automatically imbued with a value judgment, 
whether such changes are implemented depends on the cultural meanings attached to them 
(Stephan, 2015). The pressures of domestic and global economic competition have further 
increased the appeal of traditional agriculture landscapes. Many European countries continue to 
emulate the agricultural civilizations they once embodied, in contrast to the American utilitarian 
context (Stephan, 2012).  
 The Jeffersonian idea of the fiercely independent, small-holding yeoman farmer 
flourished with the expansion of the American frontier and was subsequently folded into a 
coalition of progressive, industrialist forces, united in the utilitarian rationale of productivity and 
technology (Thompson, 2001). The majority of farmland in the US (with some exceptions, 
particularly in the East Coast) is detached from urban sprawl, industrial estates, and wilderness. 
In contrast to Europe where land is perceived to attain its highest environmental value when used 
for agriculture, neither regulators nor the public in the US perceive strong positive externalities 
from farming, with some scholars maintaining that if a widely shared public good is at stake, it is 
the production of low-cost food products. There is less commitment to cultivated landscapes, as 
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land is seen to reap a higher environmental value when removed from farming and returned to its 
natural state (Baylis et al., 2008).  
 In contrast to European interactive agricultural communities that recognize associations 
with nature in food products and mixed cultural landscapes, American society embodies a 
modernist, bifurcationist culture in which the values of abundance, efficiency and simplicity tend 
to supplant neo-traditionalist concerns about culinary heritage, stable cultural identities, and the 
middle landscape. European and American societies have historically moved along distinct 
cultural trajectories, and while these trajectories do not directly cause regulatory outcomes, they 
still have an effect on the politics of GMOs in the EU and the US (Stephan, 2015).  
Nature can have plural connotations, and many Europeans (and a minority of Americans) 
perceive GMOs as a threat to one or several of these meanings, such as traditional livelihoods or 
cultural identities related to agriculture and food, or the concept of a metaphysical “natural 
order” (Stephan, 2015). European concerns about the “unnaturalness” of GMOs relates to other 
agricultural innovations, such as antibiotics in animal feed and the use of pesticides. Agriculture 
biotechnology has come to represent a sounding board for contemporary European anxieties 
about modernity, globalization, and the decline of national identity. Some feel that such 
developments have been driven by industrialization and the desire for increased productivity, 
regardless of environmental or health considerations, leading to uniform and bland food (Marris, 
2001). Support for local products, food cultures, and traditional methods are frequently seen as 
an essential element of protest against, or a reversal of, the industrialization of food (Stephan, 
2012). Such concerns also contribute to the ethical critique of the “unnaturalness” of GM crops 
and foods, crowding out utilitarian benefit-risk evaluations. These dynamics are significantly 
 29 
weaker in the US, despite the fact that other anti-GMO narratives have recently gained 
prominence (Stephan, 2015).  
The nationalization of American cuisine in the twentieth century did not glorify authentic 
ingredients as cultural heritage but rather heralded the “mass market of industrial cuisine” whose 
utilitarian motives were complemented by images of gratification and symbolic associations 
(Pilcher, 2006, p. 53). Food advertising campaigns carried a host of implicit signals about 
beauty, health, and vitality, which became embedded in the framework of basic American 
cultural themes: democracy, capitalism, industrialism, individualism, leisure, and youthfulness 
(Stephan, 2012).  
Nevertheless, a local food movement is beginning to make inroads into the largely 
homogenized US food system, with a coalition of consumer and civil society organizations 
attempting to build a broader national consensus around local and regional food systems. 
Numerous farm-to-school/college programs have been established and helped to increase the 
number of official farmers’ markets from 1,755 in 199410 to 8,144 in 2013 (Stephan, 2012; Ag 
Marketing Resource Center [AGMRC], 2018). “Culinary capital,” demonstrated through detailed 
knowledge of quality food products and dishes, is also becoming increasingly trendy (Smith, 
2009). However, the increased attention to food provenance in the US may not be as intensely 
associated with images of nature and/or traditions as in Europe, and the appeal of local food may 
sometimes be combined successfully with the potential utilitarian benefits of GM crops 
(Mazzocco & Novotorova, 2008; Stephan, 2012).  
 
 
                                                 
10 When the USDA’s Agricultural Marketing Service began tracking farmers’ markets (AGMRC, 2018). 
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CONCLUSION 
In the EU and the US, the benefit-risk analysis narrative on GMOs has been influenced 
throughout the years by numerous actors and resulted in distinct attitudes toward, and regulations 
on, genetically engineered crops and food. Circumstances in the US, such as favorable 
institutional structures, a strong agrobiotechnology industry, and government support, allowed 
for the adoption of a permissive environment of GMOs; while in Europe, public unease led to a 
negative environment and resulted in complex regulations and a de facto moratorium on GM 
crops and food in many EU member states.  
The adoption of GMOs in the US and the EU, however, it is not only a matter of the 
science, politics, or lobbying involved but also about the public preferences, which are 
influenced by cultural factors. As seen with GMO regulations in Europe, the public’s perception 
of the safety of new technology can directly impact the trajectory of technology implementation 
via the opportunities structures provided to the public to engage with and affect change in 
regulatory outcomes. The degree of trust the public places in actors and institutions is influenced 
by the wider cultural context (Stephan, 2012). The varied cultural approaches to agriculture and 
land usage seen in the US and the EU, combined with the unique histories, identities, and 
ideologies can be attributed to the different levels of trust in the food chain, to the levels of 
optimism about new technology, and the extent to which negative or positive images of GMOs 
persist. 
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